Christian R. Schubert in

Christian R. Schubert

Inquirer · DISC type cd
Advisory Board Member at Blackbird Laboratories
📍 Cambridge, Massachusetts, United States

Christian R. Schubert is the Global Head of AbbVie Ventures, leading investments in early-stage biotech. A trained geneticist, neurobiologist, and biochemist with a Ph. D. from MIT and a Postdoctoral Fellowship from Harvard Medical School, he has deep operational expertise in company creation, R&D, and business development across global biotech hubs.

He is passionate about advancing patient care through scientific entrepreneurship. His work involves identifying and funding transformational scientific opportunities and building relationships with emerging scientific leaders to develop tomorrows cures. There is no publicly available information regarding his personal life or hobbies.

Unique fact: Dr. Schubert transitioned from a hands-on scientist and educator into an early-stage venture capital investor, bridging deep scientific knowledge with biopharmaceutical investment strategy.

Read the full overview →
Experience
3 Years
Current Role
Advisory Board Member
Job Level
Senior
Location
Cambridge, Massachusetts, United States
Personality Overview

How Christian shows up

ROI Conscious
Demanding
Upfront

They respond well to confident salespeople. They focus on objectivity in a pitch and pay little attention to bells and whistles. They care equally about the product and its potential impact.

Priorities

Topics Christian cares about

Early-Stage Biotech Investing
His role focuses on Seed and Series A investments in therapeutic opportunities to gain access to next-generation science for AbbVie.
Therapeutic Innovation
He actively seeks innovations in AbbVie's core R&D interests, including immunology, oncology, neuroscience, and aesthetics.
+6 more topics Login to view topics
Career

Work history

2025
Advisory Board Member
Blackbird Laboratories
8-2024
Observer | Board of Directors
Soufflé Therapeutics
10-2023
Observer | Board of Directors
Umoja Biopharma
9-2023
Member | Board of Directors
ReAx Biotechnologies
9-2023
Observer | Board of Directors
Aquinnah Pharmaceuticals
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2009 - 2012
Postdoctoral Fellowship (Boston Children's Hospital)
Harvard Medical School
2005 - 2009
Doctor of Philosophy (Ph.D.)
Massachusetts Institute of Technology
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Christian. Free, 10 seconds.